LF
R Oregon Senate · District 30

Sen. Lynn Findley

Contact Email
Compare
Total votes
3,708
all sessions
Attendance
94%
193 missed
Near the chamber average
With party
92%
of cast votes
Lower than 88% of chamber peers
Bipartisan score
6%
crosses aisle rarely
Higher than 83% of chamber peers
Sponsored
408
bills & resolutions
Higher than 79% of chamber peers
Committees
0
assignments
408 bills and resolutions

Sponsored bills

Total
408
Primary
163
Co-sponsor
245
This page
408
matching current filters
Primary HB 2456
Passed · Oregon House · Lead sponsor
Relating to Eastern Oregon Border Economic Development Region housing; prescribing an effective date.

Allows counties to partition and rezone up to 200 acres of lands within Eastern Oregon Border Economic Development Region from exclusive farm use to residential uses. Continues any applicable farm use tax deferral and valuation on properties in region until redeveloped for sale or five years after rezoning. Applies to property tax years beginning on or after July 1, 2020, and before July 1, 2031. ] Entitles owner to income tax credit of up to $5,000 on sale of new residential dwelling on rezoned property. Applies to tax years beginning on or after January 1, 2020, and before January 1, 2026. ] Takes effect on 91st day following adjournment sine die.

Passed Jul 1, 2019 0 co-sponsors
Co-sponsor SB 872
In committee · Oregon Senate · Co-sponsor
Relating to the cost of prescription drugs.

Requires pharmaceutical manufacturers to report to Department of Consumer and Business Services total cost of ] amount of money spent on patient assistance programs , and ] information on financial assistance provided to pharmacies, government agencies and advocacy organizations and total amount of financial incentives paid to each pharmacy benefit manager . Excludes proprietary information from disclosure on department's website. ] Exempts from public disclosure information reported to department until department posts to website all information reported by manufacturer. Requires state-sponsored programs that use pharmacy benefit managers to use fee-only pharmacy benefit managers. Requires insurers to post specified information regarding formulary, tiers and costs for small employer and individual health benefit plans to insurer's website. Requires 60-day advance notice to department and to enrollees adversely affected by change in formulary. Requires insurer and allows pharmacy to notify insured that if cash ] retail price for drug is less than insured's cost-share ] out-of-pocket cost for drug using pharmacy benefit , insured may pay cash ] retail price and expense must be counted ] if requested by enrollee, insurer must count cost toward deductible or out-of-pocket maximum. Requires State Board of Pharmacy to prescribe by rule notice of enrollee's rights for distribution to pharmacy customers and to translate notice into multiple languages. Requires hospitals and other medical providers to disclose in patient billing information regarding mark-up on price of drug. Also requires billing to disclose price of drug charged to specified state agencies and insurers ] report to Oregon Health Authority information regarding 50 most prescribed drugs and 50 most expensive drugs prescribed by provider . Requires specified state agencies to report to Legislative Assembly on high-cost drugs. Requires Oregon Health Authority to refer to Pharmacy and Therapeutics Committee any drug exceeding specified cost. Requires patient advocacy organization with budget ] annual gross receipts exceeding $50,000 that has registered lobbyist in this state to report to Oregon Government Ethics Commission and Oregon Health Authority ] specified information regarding funding received from participants in pharmaceutical supply chain. Requires pharmacy benefit managers to report to Department of Consumer and Business Services and plan sponsors specified information regarding rebates, reimbursements, fees and incentives paid for drugs by manufacturers, insurers and pharmacies. Requires insurers to include with rate filing certified statement regarding insurers' use of rebates. Requires drug advertisement to disclose wholesale price of drug. ] Modifies responsibilities of Task Force on Fair Pricing of Prescription Drugs and requires report of findings, by September 15, 2020, to interim committees of Legislative Assembly related to health. Modifies reporting to department by insurers about costly drugs reimbursed by health benefit plans. Requires pharmaceutical manufacturers that register with State Board of Pharmacy to also register with department. Requires department to adopt registration fee based on reasonable cost to department to administer specified provisions.

In committee Jun 30, 2019 1 co-sponsor
Co-sponsor SB 522
Signed into law · Oregon Senate · Co-sponsor
Relating to beverage containers.

Prohibits person from , with intent to defraud, intentionally ] returning for refund value during one day 25 ] 50 or more individual beverage containers that person knows or has good reason to know ] were not sold in this state. Punishes violation by maximum fine of $250.

Signed into law Jun 17, 2019 1 co-sponsor
Co-sponsor HB 2953
Signed into law · Oregon House · Co-sponsor
Relating to the impacts of Good Neighbor Authority Agreement projects.

Requires State Forestry Department to report biennially to committee of Legislative Assembly regarding environmental and employment impacts of ] outcomes from all projects pursued in state under Good Neighbor Authority Agreement projects funded in whole or in part by moneys made available to department for project purposes ].

Signed into law Jun 17, 2019 1 co-sponsor
Co-sponsor SB 394
Signed into law · Oregon Senate · Co-sponsor
Relating to translator districts.

Permits translator districts to use specified technologies. Expands authority of translator districts to distribute signals using alternative methods.

Signed into law Jun 17, 2019 1 co-sponsor
Showing 381 to 390 of 408 bills
Previous 1 38 39 40 41 Next